Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066339
Status:
COMPLETED
Last Update Posted:
2012-07-18
First Post:
2003-08-06
Brief Title:
Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-10012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None